SEC Form 4 · accession 0001209191-15-027545
AGIOS PHARMACEUTICALS, INC. · AGIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Glenn Goddard
Officer — Senior Vice President, Finance
Period of report
Mar 16, 2015
Accepted (ET)
Mar 18, 2015 · 5:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001439222
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Mar 16, 2015 | M | 455 | $0.69 | A | 455 | D | |
| Common stock | Mar 16, 2015 | M | 3,477 | $23.10 | A | 3,932 | D | |
| Common stock | Mar 16, 2015 | M | 6,068 | $31.64 | A | 10,000 | D | |
| Common stockF3 | Mar 16, 2015 | S | 10,000 | $106.24 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F4 | $0.6875 | Mar 16, 2015 | M | 455 | D | — | Sep 14, 2021 | Common stock | 455 | 120,814 | D |
| Stock option (right to buy)F5 | $23.10 | Mar 16, 2015 | M | 3,477 | D | — | Aug 27, 2023 | Common stock | 3,477 | 117,337 | D |
| Stock option (right to buy)F6 | $31.64 | Mar 16, 2015 | M | 6,068 | D | — | Mar 4, 2024 | Common stock | 6,068 | 111,269 | D |
Explanation of responses
- F1This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- F2This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- F3The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $105.30 to $107.75. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F4This option was granted on September 15, 2011. The shares underlying this option vest as to 25% of the underlying shares on September 15, 2012, with the remaining 75% vesting in 36 equal monthly installments thereafter.
- F5This option was granted on August 28, 2013. The shares underlying this option vest as to 25% of the underlying shares on August 28, 2014, with the remaining 75% vesting in 36 equal monthly installments thereafter.
- F6This option was granted on March 5, 2014. The shares underlying this option vest as to 25% of the underlying shares on March 5, 2015, with the remaining 75% vesting in 36 equal monthly installments thereafter.